Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ASML Holding NV (ASML) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance

ASML Holding NVTrade
IDEXX Laboratories, Inc.Trade

Price performance (Past 24H)

Key statistics

ASML Holding NV vs IDEXX Laboratories, Inc. — how do they compare? ASML Holding NV trades at $1,751.71 (market cap $688.66B), while IDEXX Laboratories, Inc. trades at $567.19 (market cap $44.46B). The key difference: ASML Holding NV is far larger — about 15.5× IDEXX Laboratories, Inc.'s market cap, and ASML Holding NV pays a 0.49% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.

ASMLIDXX
Market Cap
$688.66B$44.46B
Sector
TechnologyHealth
52-Week High
$1.99K$766.68
52-Week Low
$689.63$514.61
Enterprise Value
$682.20B$45.36B
Dividend Yield
0.49%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ASML Holding NV

ASML trades at $1,797.32, down 0.38% on the day, with technical indicators showing a bullish trend despite recent volatility. The company reported strong Q1 2026 earnings that beat expectations, with revenue reaching $32.67B in 2025 and net income margins of 29.71%. Analyst consensus remains strongly positive with 56.82% buy ratings and a $2,210 price target, though elevated valuation ratios (P/E 61.03) warrant caution.

ASML maintains a dominant position in advanced semiconductor equipment with robust profitability and growth prospects driven by AI infrastructure demand. Key risks include China export restrictions, competitive pressures, and high valuation multiples. The stock offers exposure to critical chip manufacturing technology but requires monitoring of earnings execution and geopolitical developments.

IDEXX Laboratories, Inc.

IDXX trades at $563.57, up 0.89% today, with a bullish technical signal and strong fundamentals. The stock shows consistent earnings beats, with Q1 2026 EPS of $3.47 surpassing estimates. Revenue grew to $4.3B in 2025, with a robust net income margin of 24.63%. Analyst consensus is bullish with a $645 price target. Recent news highlights innovation in veterinary diagnostics and AI integration.

The outlook remains positive driven by earnings growth and market leadership, though high valuation multiples pose a risk. Key catalysts include upcoming Q2 2026 results and continued demand in pet healthcare. Risks involve competitive pressures and macroeconomic sensitivity. The stock offers growth potential but requires monitoring of valuation metrics.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ASML Holding NV

Founded in 1984 and based in the Netherlands, ASML is the leader in photolithography systems used in the manufacturing of semiconductors. Photolithography is the process in which a light source is used to expose circuit patterns from a photomask onto a semiconductor wafer. The latest technological advances in this segment allow chipmakers to continually increase the number of transistors on the same area of silicon, with lithography historically representing a meaningful portion of the cost of making cutting-edge chips. Chipmakers require next-generation EUV lithography tools from ASML to continue past the 5-nanometer process node. ASML's products are used at every major semiconductor manufacturer, including Intel, Samsung, and TSMC.

Read more on ASML

About IDEXX Laboratories, Inc.

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.

Read more on IDXX